|

Diclofenac Potassium Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CGP 45840B, Cambia, Cataflam, Zipsor

Pipeline

Phase 2: 1

Top Sponsors

  • Emory University1

Indications

  • Advanced Lung Non-Small Cell Carcinoma1
  • Stage III Lung Cancer AJCC v81
  • Stage IV Lung Cancer AJCC v81
  • Metastatic Lung Non-Small Cell Carcinoma1
  • Lung Cancer1

Atlanta, Georgia1 trial

Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

Emory University Hospital Midtown

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.